GlassScriptPhysician profile
Michael Divita
NPI 1972845246
$30,296.14
in general payments reported to CMS, 2019-2025
38 companies · $2,410 in 2025
The $2,410 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $2,767 · 2021: $518 · 2022: $3,550 · 2023: $3,632 · 2024: $4,776 · 2025: $2,410.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,450 · Travel and Lodging: $3,368.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,449.76 |
| Travel and Lodging | $3,368.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $10,765.03 | 2019-2020 | |
| Abbott Laboratories | $4,370.22 | 2019-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit, Amplatzer |
| Abiomed | $2,337.76 | 2019-2025 | Impella |
| Cardiovascular Systems INC. | $2,224.68 | 2019-2023 | Diamondback Peripheral |
| Datascope Corp. | $2,131.19 | 2022 | |
| Ancora Heart, INC. | $1,766.75 | 2023-2025 | Accucinch |
| Novartis Pharmaceuticals Corporation | $1,174.99 | 2019-2025 | |
| Janssen Scientific Affairs, LLC | $1,089.18 | 2022-2024 | Xarelto |
| Endotronix, INC. | $416.81 | 2021-2025 | Cordella Pulomonary Artery Pressure Sensor |
| Pfizer INC. | $377.88 | 2019-2025 | |
| Boston Scientific Corporation | $348.69 | 2019-2025 | Avvigo Guidance System |
| Getinge USA Sales, LLC | $340.84 | 2022 | |
| Amgen INC. | $281.06 | 2019-2025 | Repatha, Repatha |
| Daiichi Sankyo INC. | $269.27 | 2022-2024 | Injectafer |
| Boehringer Ingelheim Pharmaceuticals, INC. | $267.91 | 2022-2023 | Jardiance |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $245.80 | 2019-2025 | Farxiga, Wainua |
| Shockwave Medical, INC | $215.83 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic, INC. | $191.42 | 2021 | |
| Novo Nordisk INC | $189.32 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $173.08 | 2023-2025 | Verquvo, Winrevair, Capvaxive |
| Acist Medical Systems, INC. | $147.06 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $135.31 | 2019-2024 | Lifevest |
| Alnylam Pharmaceuticals INC. | $134.76 | 2025 | Onpattro |
| Irhythm Technologies, INC. | $79.73 | 2023 | Zio Xt Patch |
| Cardinal Health 200 LLC | $59.07 | 2020 | |
| Janssen Pharmaceuticals, INC | $57.13 | 2019-2023 | Xarelto |
| Heartflow, INC. | $57.01 | 2019 | |
| Terumo Medical Corporation | $56.09 | 2019-2020 | |
| Kestra Medical Technology Services, INC. | $53.91 | 2025 | Assure Wcd |
| Bridgebio Pharma, INC. | $46.99 | 2025 | Attruby |
| Scpharmaceuticals INC. | $43.77 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $42.63 | 2023-2025 | |
| Lexicon Pharmaceuticals, INC. | $41.54 | 2024 | |
| Nuwellis, INC. | $37.13 | 2023 | Aquadex Smartflow Console |
| Cvrx, INC. | $35.57 | 2025 | Barostim Neo System |
| One Lambda, INC. | $33.63 | 2024 | |
| Amarin Pharma, INC. | $29.42 | 2019-2020 | |
| Portola Pharmaceuticals, LLC | $27.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Divita listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.